Skip to main content
HYDROGEN STUDIESPOWERED BY ECHO WATER

Hydrogen Gas Protects Hearing from Chemo Drug Damage in Mice

Hydrogen protects auditory hair cells from cisplatin-induced free radicals

Research hubs: Brain & Nervous System

This research was done on cells or tissue in a lab, not in people or animals.

Scientific visualization of hydrogen therapy research for Hydrogen protects auditory hair cells from cisplatin-induced free radicals
Evidence type
Laboratory study (cells or tissue)
Authors
Yayoi S. Kikkawa, Takayuki Nakagawa, Mirei Taniguchi, Juichi Ito
Journal
Neuroscience Letters
Year
2014
Study Type
Mouse
Delivery
Saline (Dissolved)
Dose
hydrogen gas dissolved directly into the media
Duration
2 days
Outcome
Positive
Peer Reviewed
Yes
Cited by
35 (OpenAlex, as of November 2026)
Country
Japan

TL;DR

Breathing in molecular hydrogen gas can help protect the hearing cells in the ear from damage caused by a common cancer drug.

Key Finding

Molecular hydrogen gas reduced cisplatin-induced auditory hair cell loss and decreased harmful free radical formation in mouse cochlear tissue.

Summary

Cisplatin is a cancer drug that can damage hearing by creating harmful molecules called free radicals in the inner ear. Researchers tested whether molecular hydrogen (hydrogen gas dissolved in liquid) could protect auditory hair cells—the cells responsible for hearing—from cisplatin damage in mouse ear tissue. Hydrogen gas significantly reduced hair cell loss and lowered the levels of harmful free radicals, suggesting it might help preserve hearing in cancer patients receiving cisplatin treatment.

Practical Takeaway

This is an early laboratory study in mouse tissue, not human testing. While the results are promising and suggest hydrogen may have protective potential against cisplatin-related hearing damage, much more research—including human trials—would be needed before any clinical application. The findings are too preliminary to inform personal health decisions about hydrogen water or hydrogen therapy at this time.

Abstract (excerpt)

Cisplatin is a widely used chemotherapeutic agent for the treatment of various malignancies. However, its maximum dose is often limited by severe ototoxicity. Cisplatin ototoxicity may require the production of reactive oxygen species (ROS) in the inner ear by activating enzymes specific…

Read the full abstract on PubMed